Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) [Phase 3]
The Phase 3 TRINOVA-2 trial of trebananib (AMG 386) in fallopian tube cancer, ovarian cancer, and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]
Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked a…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies [Phase 1]
This is a completed Phase 1 trial evaluating hyperthermic intraperitoneal oxaliplatin for peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial of enzastaurin in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating veliparib in combination with radiation therapy in adults with advanced solid tumors featuring peritoneal carcinoma…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
CLINICAL_TRIALS approval · 2017-10-25Clinical Trial Update: Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Update notes that Olaparib is available via an expanded access program as maintenance therapy for ovarian, fallopian tube, or primary perito…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating recombinant measles virus vaccine therapy and oncolytic virus therapy for progressive, recurrent, or refra…
-
FDA approval · 2017-09-14FDA Approved: MVASI — Original Application (Amgen, Inc)
The FDA approved MVASI (bevacizumab-awwb) from Amgen as a biosimilar to Avastin, marking the original application granting U.S. approval for…
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy [Phase 2]
This Phase 2 trial evaluated the combination of sargramostim with paclitaxel albumin-stabilized nanoparticle formulation in patients with ad…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating Karenitecin for persistent or recurrent ovarian epithelial cancer…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial CT-2103 for recurrent or persistent ovarian epithelial cancer or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without fosbretabulin tromethamine in recurrent or persistent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Phase 2]
Phase II trial evaluating bevacizumab followed by consolidation therapy for advanced ovarian cancer and related tumors; results have been po…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating cediranib maleate in patients with persistent, recurrent, or refractorily advanced ovarian epithelial, fal…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluating a second-line intravenous therapy for recurrent platinum-sensitive ovarian, fallopia…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of RO4929097 in recurrent/metastatic epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has compl…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bevacizumab in patients with ovarian cancer or primary perit…
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
This clinical trial update outlines research into the inflammatory mechanisms that occur after cytoreductive surgery with hyperthermic intra…
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of DCVax-L vaccination combined with CD3/CD28-costimulated autologous T-cells for recurrent ovarian cancer or primary peri…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer [Phase 1]
A Phase I trial evaluating stereotactic body radiotherapy for metastatic or recurrent platinum-resistant ovarian cancer was terminated.